Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Selecta Biosciences Inc (NASDAQ:SELB)

9.38
Delayed Data
As of Jan 22
 +0.11 / +1.19%
Today’s Change
8.40
Today|||52-Week Range
24.02
-4.38%
Year-to-Date
No recent news for Selecta Biosciences Inc.

Today’s Trading

Previous close9.27
Today’s open9.29
Day’s range9.20 - 9.89
Volume503,510
Average volume (3 months)231,141
Market cap$204.6M
Data as of 4:00pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)-123.15%
Earnings growth (this year)+26.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+34.47%
P/E ratioNM
Price/Sales22.27
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
MRSNMersana Therapeutics...+0.39+2.42%
NSTGNanoString Technolog...+0.14+1.68%
BLCMBellicum Pharmaceuti...+0.74+9.49%
GERNGeron Corp+0.05+2.60%
Data as of 4:00pm ET, 01/22/2018

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$8.1M
Annual profit (last year)-$36.2M
Net profit margin-447.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Werner Cautreels
COO, Senior Vice President-Research &
Development
Lloyd Johnston
Corporate headquarters
Watertown, Massachusetts

Forecasts